{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-002678","form_type":"8-K","ticker":"ALKS","cik":"0001520262","company_name":"Alkermes plc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.477128+00:00","generated_at":"2026-06-07T02:14:33.108051+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Alkermes to present at J.P. Morgan Healthcare Conference; highlights profitability and neuroscience focus","bullets":["Presentation on Jan 10, 2024, titled 'Profitable, Pure-play Neuroscience Company'.","CEO Richard Pops to present at the 42nd Annual J.P. Morgan Healthcare Conference.","No specific financial or operational data disclosed in the excerpt provided."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-002678","json":"https://secwatch.observer/filing/0000950170-24-002678.json","markdown":"https://secwatch.observer/filing/0000950170-24-002678.md","text":"https://secwatch.observer/filing/0000950170-24-002678.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520262/000095017024002678/0000950170-24-002678-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520262/000095017024002678/alks-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:14:33.108051+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}